Metropolitan Hosp. NICHD CRS — New York, New York

Metropolitan Hosp. NICHD CRS is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Metropolitan Hosp. NICHD CRS has participated in 13 clinical trials.

Therapeutic areas: HIV Infections, H1N1 Influenza Virus, Measles.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metropolitan Hosp. NICHD CRS?

Metropolitan Hosp. NICHD CRS has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metropolitan Hosp. NICHD CRS conducted?

Metropolitan Hosp. NICHD CRS has 13 clinical trials on record. Their work covers HIV Infections, H1N1 Influenza Virus, Measles.

Is Metropolitan Hosp. NICHD CRS accredited by Crixeo Health?

Metropolitan Hosp. NICHD CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metropolitan Hosp. NICHD CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.